Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR

Written by Emily J. Thompson, Senior Investment Analyst

Source: PRnewswire

Updated: Nov 07 2025

0mins

Source: PRnewswire

Class Action Lawsuit Announcement: The DJS Law Group has announced a class action lawsuit against Jasper Therapeutics, Inc. for alleged violations of securities laws, specifically related to misleading statements made by the company during the class period from November 30, 2023, to July 3, 2025.
Shareholder Participation: Shareholders who purchased JSPR shares during the specified period are encouraged to contact the firm for potential lead plaintiff appointments, although this is not necessary to participate in any recovery.
Allegations Against Jasper: The lawsuit claims that Jasper Therapeutics made false statements regarding its manufacturing controls and clinical trials, which were jeopardized due to issues with third-party vendors, leading to misleading public disclosures.
Next Steps for Investors: Interested shareholders can register to receive updates on the case through a monitoring software, with no cost or obligation to participate in the lawsuit.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free